These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11286428)

  • 1. Hepatitis C in methadone maintenance patients: prevalence and public policy implications.
    McCarthy JJ; Flynn N
    J Addict Dis; 2001; 20(1):19-31. PubMed ID: 11286428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.
    Zhou W; Wang X; Zhou S; Xie N; Liu P; Luo L; Peng J; Liu M; Desrosiers A; Schottenfeld R; Chawarski MC
    Addiction; 2015 May; 110(5):796-802. PubMed ID: 25529103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of heroin dependent patients admitted to a methadone treatment program].
    Sanvisens A; Rivas I; Faure E; Muñoz T; Rubio M; Fuster D; Tor J; Muga R
    Med Clin (Barc); 2014 Jan; 142(2):53-8. PubMed ID: 23337454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.
    Ng MH; Chou JY; Chang TJ; Lee PC; Shao WC; Lin TY; Chen VC; Gossop M
    Addict Behav; 2013 Apr; 38(4):2089-93. PubMed ID: 23403277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control study.
    Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R; Levine RA
    J Addict Dis; 2010 Jul; 29(3):359-69. PubMed ID: 20635285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
    N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
    Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
    Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
    Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
    J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.
    Zeiler I; Langlands T; Murray JM; Ritter A
    Drug Alcohol Depend; 2010 Aug; 110(3):228-33. PubMed ID: 20430537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
    Miller CL; Strathdee SA; Li K; Kerr T; Wood E
    Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C, B, D, and A: contrasting features and liver function abnormalities in heroin addicts.
    Tennant F
    J Addict Dis; 2001; 20(1):9-17. PubMed ID: 11286434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from a methadone treatment program in Laos, 1972-75.
    Westermeyer J; Soudaly C
    Drug Alcohol Depend; 1984 Mar; 13(2):89-106. PubMed ID: 6609808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.